GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides No Additive Long-Term Protection After Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin~!2010-05-17~!2010-05-28~!2010-07-20~!

Open Cardiovascular Medicine Journal - United Arab Emirates
doi 10.2174/1874192401004010151

Related search